Genoray Co., Ltd. (KOSDAQ:122310)
South Korea · Delayed Price · Currency is KRW 3,260.00
-20.00 (-0.61%)
At close: Aug 21, 2026
Genoray Market Cap
Genoray has a market cap or net worth of 41.51 billion as of August 21, 2026. Its market cap has decreased by -36.48% in one year.
Market Cap
41.51B
Enterprise Value
56.00B
Revenue
108.27B
Ranking
n/a
PE Ratio
181.93
Stock Price
3,260.00
ChartMarket Cap Chart
Since May 28, 2018, Genoray's market cap has decreased from 150.47B to 41.51B, a decrease of -72.42%. That is a compound annual growth rate of -14.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 41.51B | -17.86% |
| Dec 30, 2025 | 50.53B | -27.84% |
| Dec 30, 2024 | 70.03B | -26.75% |
| Dec 28, 2023 | 95.60B | -11.63% |
| Dec 29, 2022 | 108.18B | -23.55% |
| Dec 30, 2021 | 141.51B | 1.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| May 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Remed | 80.79B |
| Hironic | 65.62B |
| SELVAS Healthcare | 61.47B |
| DRGEM | 54.91B |
| QuantaMatrix | 48.83B |
| JPI Healthcare | 45.95B |
| Genesystem | 33.02B |
| UXN Co., Ltd. | 31.86B |